Structural Heart Devices Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

TAVR (Transcatheter Aortic Valve Replacement) is the fastest growing segment, North America is the largest market globally

The Global Structural Heart Devices Market, valued at USD 7.20 Billion in 2024, is projected to experience a CAGR of 9.11% to reach USD 12.15 Billion by 2030. Structural heart devices comprise medical implants and systems addressing anatomical defects or disorders of the heart's valves, chambers, or major arteries, typically via minimally invasive procedures. Market growth is fueled by the escalating global prevalence of structural heart diseases, particularly in the aging population. The increasing adoption of minimally invasive interventions, such as Transcatheter Aortic Valve Replacement, offering reduced recovery times and improved patient outcomes, further propels market expansion, alongside ongoing technological advancements.

Key Market Drivers

The rising prevalence of structural heart diseases represents a fundamental driver for the global structural heart devices market, creating a substantial and expanding patient demographic requiring advanced therapeutic interventions. Conditions such as valvular heart disease, cardiomyopathy, and congenital heart defects, which often necessitate mechanical correction or replacement, are increasingly being diagnosed due to improved awareness and diagnostic capabilities. This growing disease burden directly translates into a higher demand for innovative devices like transcatheter heart valves and annuloplasty rings. For instance, according to "The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management", in March 2023, more than 4% of people over 75 years old were found to have a clinically relevant tricuspid regurgitation, highlighting the significant need for effective treatment solutions for various structural heart conditions beyond previously highlighted disorders.

Key Market Challenges

The substantial cost associated with advanced structural heart devices presents a significant impediment to the growth of the Global Structural Heart Devices Market. These high expenses directly impact healthcare budgets and reimbursement policies, particularly in health systems with constrained financial resources. This economic barrier can restrict the widespread adoption of innovative therapies, limiting access for a broader patient population across different economic regions.

Key Market Trends

Advancements in Interventional Imaging and AI-Guided Navigation

This trend underscores the evolving sophistication of imaging modalities and the integration of artificial intelligence in guiding structural heart interventions. These technological enhancements improve procedural precision and safety, ultimately contributing to favorable patient outcomes. AI-driven algorithms assist in real-time visualization, optimal device placement, and comprehensive pre-procedural planning, which can refine procedural pathways. For instance, according to the American College of Cardiology's Annual Scientific Session, in March 2025, patients whose evaluation was non-invasively guided by a novel, AI-powered technique underwent approximately 10% fewer procedures with comparable outcomes to those guided by ultrasound-based imaging.

Key Market Players Profiled:

• Abbott Laboratories, Inc.
• Edwards Lifesciences Corporation
• Medtronic Plc
• Boston Scientific Corporation
• Lepu Medical Technology Holding Company
• TTK Healthcare Limited
• Biomerics, LLC
• Braile Biomedic
• Artivion, Inc.
• JenaValve Technology Inc

Report Scope:

In this report, the Global Structural Heart Devices Market has been segmented into the following categories:

By Type:

• SAVR (Surgical Aortic Valve Replacement)
• TAVR (Transcatheter Aortic Valve Replacement)
• Mitral Repair (Annuloplasty)
• LAAC (Left Atrial Appendage Closure)

By Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Structural Heart Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.